Rizatriptan shows no advantage over placebo within first hour for vestibular migraine

by

A rigorous randomized clinical trial of rizatriptan conducted by UCLA and Mayo Clinic researchers failed to outperform placebo in relieving the acute symptoms of vestibular migraine.

Leave A Comment

Your email address will not be published. Required fields are marked *